Results 241 to 250 of about 128,630 (294)

Adverse events administering glucagon-like peptide-1 receptor agonists: a cross-sectional study. [PDF]

Health Aff Sch
Mattingly TJ, Duru EE, Conti RM.
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists in Chronic Kidney Disease: Mechanisms and Clinical Perspectives. [PDF]

Kidney Med
Meier M, Cummings J, Abdelsaid M, Feliciano J, Eusebe J, Stirn H, Coucha M.   +6 more
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) for Obesity and Symptoms in Menopause: A Review. [PDF]

Cureus
Graczyk NA, Bisschops J.
europepmc   +1 more source

Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits. [PDF]

J Clin Invest
Wong CK, Drucker DJ.
europepmc   +1 more source

Glucagon-like Peptide-1 Receptor Agonists and Ocular Disease: Mechanisms, Evidence and Therapeutic Perspectives. [PDF]

Int J Mol Sci
Gong X, Örge FH.
europepmc   +1 more source

Human Islet

Cell Proliferation, EarlyView.
Jiaqi Zou, Shen Li, Hongxing Fu, Mei Zhang, Anbin Hu, Xiaohui Tian, Yuanyuan Du, Lingling Wei, Xuchun Chen, Jie Gao, Rui Liang, Xinshun Feng, Yang Li, Ying Wang, Xiangheng Cai, Peng Sun, Xuejie Ding, Boya Zhang, Tengli Liu, Na Liu, Jie Hao, Lei Wang, Hongling Zhao, Jiani Cao, Aijin Ma, Lijun Zhu, Qiyuan Li, Qiang Wei, Xiaoming Ding, Ying Cheng, Tongbiao Zhao, Shusen Wang   +31 more
wiley   +1 more source

Signals arising from the gastrointestinal tract that affect food intake (Syömiseen vaikuttavat mahasuolikanavan signaalit) [PDF]

Purhonen, Anna-Kaisa
core